Bio-Techne Corporation logo
TECHBio-Techne Corporation

Earnings Per Share (EPS): 0.69

popular:market cap|pe ratio|revenue|price history|total return

Is the earnings per share (EPS) high or low?

The earnings per share (EPS) of 0.69 is 45% below its 5-year average of 1.25, near the low end of its 5-year range (0.47–1.81).

As of Sunday, June 28, 2026. 10.39% below its 12-month average of 0.77.

P/E Ratio|EPS CAGR|Net Income|Earnings Yield|All Metrics
EPS

TECH Earnings Per Share (EPS)

0.33

Reported quarterly EPS; no daily interpolation.

+243.39% 5Y

TECH Quarterly EPS Growth (YoY)

EPS growth vs the same quarter one year earlier, last 20 quarters.

TECH Earnings Per Share (EPS)

TECH Average Earnings Per Share (EPS) Chart

TECH Earnings Per Share (EPS)

TECH Current vs Average Earnings Per Share (EPS) Chart

TECH Earnings Per Share (EPS) Metrics

EARNINGS PER SHARE (EPS)

0.69

EARNINGS PER SHARE (EPS) AVG TTM

0.77

EARNINGS PER SHARE (EPS) AVG 3Y

1.27

EARNINGS PER SHARE (EPS) AVG 5Y

1.25

EARNINGS PER SHARE (EPS) AVG 10Y

0.99

EARNINGS PER SHARE (EPS) AVG 15Y

0.74

EARNINGS PER SHARE (EPS) AVG 20Y

0.69

CURRENT VS TTM AVG

-10.39%

CURRENT VS 3Y AVG

-45.67%

CURRENT VS 5Y AVG

-44.73%

CURRENT VS 10Y AVG

-30.49%

CURRENT VS 15Y AVG

-7.05%

CURRENT VS 20Y AVG

-0.08%

TECH Competitors' Earnings Per Share (EPS)

NAMEMARKET CAPEARNINGS PER SHARE (EPS)TTM3Y5Y
Bio-Techne Corporation (TECH)$11.12B0.690.771.271.25
Insulet Corp. (PODD)vs ›$10.96B4.304.743.132.14
Baxter International Inc. (BAX)vs ›$11.38B-2.10-1.51-0.650.36
Charles River Laboratories International, Inc. (CRL)vs ›$10.39B-3.76-1.354.035.21
Walgreens Boots Alliance, Inc. (WBA)vs ›$10.37B-7.29-6.79-1.56-0.26
Molina Healthcare, Inc. (MOH)vs ›$11.97B3.3614.7215.4614.11
Tempus AI, Inc. (TEM)vs ›$9.80B-1.72-3.00-2.43-2.16
Henry Schein, Inc. (HSIC)vs ›$9.68B3.313.183.373.47
Revvity, Inc. (RVTY)vs ›$12.61B2.102.252.013.78
Align Technology, Inc. (ALGN)vs ›$12.78B5.965.645.439.01

EPS Comparison

Trailing EPS (TTM)

$0.69

Forward EPS (Est.)

$2.06

P/E Ratio

102.9

Formula: EPS = Net Income / Weighted Average Shares Outstanding

Why EPS matters:

  • Directly impacts stock valuation through P/E ratio
  • Used to calculate dividend coverage and payout ratios
  • Enables comparison across companies of different sizes
  • Growth in EPS often correlates with stock price appreciation

Earnings Per Share (EPS) Formula & Definition

EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Per Share (EPS) FAQ

What is the earnings per share (EPS) for Bio-Techne Corporation (TECH)?
The earnings per share (EPS) for TECH stock is 0.69.
Is Bio-Techne Corporation's earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.69 is 45% below its 5-year average of 1.25, near the low end of its 5-year range (0.47–1.81).
What is the TTM average earnings per share (EPS) for Bio-Techne Corporation (TECH)?
The TTM average earnings per share (EPS) for TECH stock is 0.77.
What is the 3Y average earnings per share (EPS) for Bio-Techne Corporation (TECH)?
The 3Y average earnings per share (EPS) for TECH stock is 1.27.
What is the 5Y average earnings per share (EPS) for Bio-Techne Corporation (TECH)?
The 5Y average earnings per share (EPS) for TECH stock is 1.25.
What is the 10Y average earnings per share (EPS) for Bio-Techne Corporation (TECH)?
The 10Y average earnings per share (EPS) for TECH stock is 0.99.
What is the 15Y average earnings per share (EPS) for Bio-Techne Corporation (TECH)?
The 15Y average earnings per share (EPS) for TECH stock is 0.74.
What is the 20Y average earnings per share (EPS) for Bio-Techne Corporation (TECH)?
The 20Y average earnings per share (EPS) for TECH stock is 0.69.

TECH Earnings Per Share (EPS) History

DATEEARNINGS PER SHARE (EPS)
2025-06-300.47
2024-06-301.07
2023-06-301.81
2022-06-301.73
2021-06-300.91
2020-06-301.50
2019-06-300.64
2018-06-300.84
2017-06-300.52
2016-06-300.70
2015-06-300.73
2014-06-300.75
2013-06-300.76
2012-06-300.76
2011-06-300.76
2010-06-300.74
2009-06-300.70
2008-06-300.66
2007-06-300.54
2006-06-300.47
2005-06-300.41
2004-06-300.32
2003-06-300.27
2002-06-300.16
2001-06-300.21
2000-06-300.16
1999-06-300.10
1998-06-300.10
1997-06-300.07
1996-06-300.06

Related Metrics

P/E RatioEPS CAGRNet IncomeEarnings YieldAll Metrics

About Bio-Techne Corporation

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Minneapolis, MN
3,100 employees
www.bio-techne.com
Healthcare / Biotechnology
Sector
Healthcare
Industry
Biotechnology
CEO
Kim Kelderman
View full financials